131 related articles for article (PubMed ID: 8972106)
1. Interspecies extrapolation of physiological pharmacokinetic parameter distributions.
Watanabe KH; Bois FY
Risk Anal; 1996 Dec; 16(6):741-54. PubMed ID: 8972106
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three physiologically based pharmacokinetic models of benzene disposition.
Bois FY; Woodruff TJ; Spear RC
Toxicol Appl Pharmacol; 1991 Aug; 110(1):79-88. PubMed ID: 1871774
[TBL] [Abstract][Full Text] [Related]
3. Benzene toxicokinetics in humans: exposure of bone marrow to metabolites.
Watanabe KH; Bois FY; Daisey JM; Auslander DM; Spear RC
Occup Environ Med; 1994 Jun; 51(6):414-20. PubMed ID: 8044234
[TBL] [Abstract][Full Text] [Related]
4. An analysis of exposure rate effects for benzene using a physiologically based pharmacokinetic model.
Bois FY; Paxman DG
Regul Toxicol Pharmacol; 1992 Apr; 15(2 Pt 1):122-36. PubMed ID: 1626064
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of benzene.
Travis CC; Quillen JL; Arms AD
Toxicol Appl Pharmacol; 1990 Mar; 102(3):400-20. PubMed ID: 2315912
[TBL] [Abstract][Full Text] [Related]
6. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling.
Kirman CR; Sweeney LM; Meek ME; Gargas ML
Regul Toxicol Pharmacol; 2003 Dec; 38(3):345-67. PubMed ID: 14623485
[TBL] [Abstract][Full Text] [Related]
7. Interspecies scaling and comparisons in drug development and toxicokinetics.
Ings RM
Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
[TBL] [Abstract][Full Text] [Related]
8. Population toxicokinetics of benzene.
Bois FY; Jackson ET; Pekari K; Smith MT
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1405-11. PubMed ID: 9118927
[TBL] [Abstract][Full Text] [Related]
9. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
10. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic parameters for interspecies scaling using allometric techniques.
Hayton WL
Health Phys; 1989; 57 Suppl 1():159-64. PubMed ID: 2606679
[TBL] [Abstract][Full Text] [Related]
12. Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: A bottom up modeling approach.
Sharma RP; Schuhmacher M; Kumar V
Toxicol Lett; 2018 Oct; 296():152-162. PubMed ID: 29958929
[TBL] [Abstract][Full Text] [Related]
13. Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models.
Krewski D; Wang Y; Bartlett S; Krishnan K
J Biopharm Stat; 1995 Nov; 5(3):245-71. PubMed ID: 8580927
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in benzene disposition in male C57BL/6N mice described by a physiologically based pharmacokinetic model.
McMahon TF; Medinsky MA; Birnbaum LS
Toxicol Lett; 1994 Dec; 74(3):241-53. PubMed ID: 7871548
[TBL] [Abstract][Full Text] [Related]
15. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
Cox LA
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
[TBL] [Abstract][Full Text] [Related]
16. Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): a computational method.
Thomas RS; Lytle WE; Keefe TJ; Constan AA; Yang RS
Fundam Appl Toxicol; 1996 May; 31(1):19-28. PubMed ID: 8998950
[TBL] [Abstract][Full Text] [Related]
17. Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo.
Cole CE; Tran HT; Schlosser PM
J Toxicol Environ Health A; 2001 Mar; 62(6):439-65. PubMed ID: 11289318
[TBL] [Abstract][Full Text] [Related]
18. Structure and parameterization of pharmacokinetic models: their impact on model predictions.
Woodruff TJ; Bois FY; Auslander D; Spear RC
Risk Anal; 1992 Jun; 12(2):189-201. PubMed ID: 1502372
[TBL] [Abstract][Full Text] [Related]
19. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development.
Mahmood I
Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864
[TBL] [Abstract][Full Text] [Related]
20. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.
Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC
J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
